News
A study led by Bellvitge links pressure in sport with eating disorders
An international study led by the HUB and IDIBELL has analyzed the impact of factors such as aesthetic pressure and disciplinary demands on people with eating disorders (EDs) who practice elite sports.
Catalonia promotes the first public bank of fecal microbiota in Spain to treat some serious intestinal infections
The Microbiota Bank of Catalonia, a pioneering initiative in the public sphere that positions the Catalan health system as a benchmark in the therapeutic use of faecal microbiota has been launched.
A study led by Bellvitge points out that fosfomycin can improve the treatment of bacteremia caused by S. aureus
Combining fosfomycin with other antibiotics can help eliminate the infection more quickly, however, is also associated with an increase in side effects.
The Clinical Research Unit in Clinical Trials revalidates its quality certification
The ISO 9001:2015 certification, granted by the Applus+ organization and globally recognized, confirms the excellence of the UICEC’s quality processes.
A Bellvitge study analyzes the clinical impact of amoxicillin resistance on invasive pneumococcal pneumonia
According to the results, amoxicillin may be associated with a less favourable clinical outcome, especially in cases with resistant strains and in people with a worse initial prognosis.
A study by the UB and IDIBELL identifies a key neurophysiological mechanism in the formation of memories in humans
A team from the Faculty of Psychology of the University of Barcelona (UB), the Institute of Neurosciences of the UB (UBNeuro) and the Bellvitge Biomedical Research Institute (IDIBELL) has identified for the first time in humans, and in a realistic environment, a key neurophysiological mechanism in memory formation: brain waves type Ripple, high-frequency electrical oscillations, […]
Quality and excellence guaranteed: the Biobank successfully passes the ISO 9001 audit
The HUB-ICO-IDIBELL Biobank has renewed its ISO 9001 certification.
SCALPEL: analyzing gene expression in high resolution
Researchers from IDIBELL and the UB present a new tool to study the post-transcriptional regulation of gene expression at single-cell resolution
Bellvitge leads the first clinical trial to evaluate antifibrotic benefit in patients with post-COVID fibrosis
The study confirms the improvement in severe lung affectation after COVID-19 thanks to the combination of pirfenidone and corticosteroids.